Although Harderian glands are especially large in rodents, many features of this retroocular gland, including its development and function, are not well established. Protein phosphatase 2A (PP2A) is a family of heterotrimeric enzymes expressed in this gland. PP2A substrate specificity is determined by regulatory subunits with leucine 309 of the catalytic subunit playing a crucial role in the recruitment of regulatory subunits into the complex in vitro.
Introduction
Harderian (lacrimal) glands are found in all vertebrates that possess a nictitating membrane, or third eyelid, and are especially large in ungulates and rodents. The Harderian gland is a large tubular alveolar tissue located within the orbit, behind the eye. It indents the extraorbital lacrimal gland, which is comparably small and located in the anterior orbit. In rodents, the Harderian gland synthesizes lipids, pheromones, porphyrins and indoles. The lipids are thought to lubricate the eye and the nictitating membrane (Buzzell, 1996) . Moreover, the Harderian gland produces saliva and has been proposed to play a role in osmoregulation, immune response, photoprotection and retinal-pineal axis establishment (Payne, 1994) . However, despite more than three centuries of investigation, many features of this gland, including its development and function, are not well understood (Buzzell, 1996) .
Several transgenic approaches have been applied either to gain insight into Harderian gland function or they happened to Mechanisms of Development 123 (2006) cause a Harderian phenotype, due to choice of promoter and transgene. Expression of oncogenes such as v-ras caused proliferative alterations ranging from hyperplasia to wide tissue destruction (Sinn et al., 1987; White et al., 1990) . In the most advanced situations, these changes were accompanied by a glandular hypertrophy (Coto-Montes et al., 1997) . These and related studies demonstrated that the Harderian gland is susceptible to hyperplasia and tumor formation, without providing insight into organogenesis and function. In int-3 transgenic mice incomplete differentiation and the presence of proliferating immature ductule cells were reported demonstrating that expression of the activated Notch-related int-3 gene causes deregulation of normal developmental control in vivo (Jhappan et al., 1992) . To address functional aspects, prolactin transgenic mice were compared with prolactin knockout mice. It was found that prolactin is required for porphyrin secretion by the Harderian gland without playing an essential role in the secretory immune function of the lacrimal gland (McClellan et al., 2001 ). Furthermore, FGF-10, a member of the fibroblast growth factor family, was shown to be required for both lacrimal and Harderian gland formation (Govindarajan et al., 2000) . In the present study, we obtained transgenic mice with a delayed and incomplete postnatal development (hypoplasia) of the Harderian gland by expressing a mutant form of the catalytic subunit of protein phosphatase 2A (PP2A), L309A. PP2A is a highly abundant and ubiquitously expressed serine/threonine-specific protein phosphatase with important roles in embryonic development and differentiated tissues (Janssens and Goris, 2001) . The PP2A holoenzyme is a heterotrimer consisting of a scaffolding A, a regulatory B, and a catalytic C subunit. The scaffolding subunit is a 65 kDa protein, which associates with the 36 kDa catalytic subunit to form a core dimer (Kamibayashi et al., 1992; Groves et al., 1999) . This assembles with various regulatory subunits to form heterotrimers with distinct localization and substrate specificity (McCright et al., 1996; Tehrani et al., 1996; Strack et al., 1998; Moreno et al., 2000) . Four B subunit families have been identified so far, termed B/PR55, B 0 /PR56/PR61, B 00 /PR59/ PR72/PR130 and B 000 /PR93/PR110 (Janssens and Goris, 2001) . In contrast to Drosophila where each subunit is encoded by a single gene, mammals express at least two scaffolding, two catalytic, four B, at least eight B 0 , four B 00 , and two B 000 regulatory isoforms. As a result, a total of more than 72 PP2A holoenzymes can be generated. Taking into account the different splice variants, this number may be even higher (Schmidt et al., 2002; Martens et al., 2004) . Our previous work aimed at understanding PP2A function by a null mutation of the catalytic subunit PPP2CA, which was embryonically lethal (Gotz et al., 1998; Gotz et al., 2000; Gotz and Schild, 2003) . To circumvent lethality, we previously used a dominant negative mutant approach and expressed the catalytic mutant L199P in the brain of transgenic mice. PP2A activity was chronically reduced and the microtubuleassociated protein tau was abnormally phosphorylated, with similarities to lesions in the Alzheimer's disease brain (Kins et al., 2001; Kins et al., 2003; Chen et al., 2004) . As the L199P mutation is in the catalytic core of the catalytic subunit, it abolishes the catalytic activity, possibly without affecting holoenzyme assembly (Evans et al., 1999) (but see: (Ogris et al., 1999; Yu et al., 2001) ).
Here we expressed a further mutant form of the catalytic subunit PPP2CA, L309A, in brain and Harderian gland of transgenic mice, with functional consequences for Harderian gland development. Leucine 309 is located in the carboxyterminus of the catalytic subunit. The DYFL motif at position 306-309 is highly conserved and holoenzyme assembly, i.e. recruitment of regulatory subunits into the PP2A complex, is determined by post-translational modifications of this motif (Ogris et al., 1997) . These modifications include tyrosine phosphorylation and methylation of leucine 309 Tolstykh et al., 2000; Wu et al., 2000; Yu et al., 2001 ). Specifically, it was shown that the L309A mutant is defective in binding distinct subunits in vitro and in yeast (Bryant et al., 1999; Evans and Hemmings, 2000) .
Results

Expression of the dominant negative mutant form of the catalytic subunit of PP2A, L309A, in Harderian gland
An expression vector with the neuron-specific elements of the murine Thy1.2 (mThy1.2) promoter was used to express the human mutant form of PPP2CA, L309A, in mice. Because of the substitution of leucine by alanine, L309A cannot be carboxymethylated anymore. To facilitate detection of the mutant protein, a haemagglutinin (HA) epitope was fused to the aminoterminus (Evans et al., 1999; Kins et al., 2001) . Seven founders transmitted the transgene in a Mendelian fashion, three of which expressed the transgene at high levels (data not shown). Although expression of transgenes under control of the mThy1.2 promoter is mainly restricted to postmitotic neurons, it has also been reported in immature neuroblast layers of the central nervous system, and in several organs and tissues outside the nervous system (Campsall et al., 2002) .
One particular line (here referred to as L309A mice) was chosen for further analysis, as expression was strong in the Harderian gland (Fig. 1A) and, in addition, in several distinct brain areas implicated in Alzheimer's disease (Schild et al., 2006) . No expression was found in lung, liver, heart, spleen and skeletal muscle of transgenic mice or in any tissue of wild-type (WT) littermate controls (Fig. 1A) . Western blot analysis of brain extracts with antibodies directed against epitopes conserved between the human and murine catalytic subunit of PP2A revealed that total levels were not increased upon expression of the mutant protein (data not shown). This finding is consistent with previous observations in mice (Gotz et al., 1998; Kins et al., 2001; Kins et al., 2003) , and with tissue culture experiments demonstrating that protein levels of the catalytic subunit are subject to an effective autoregulatory mechanism keeping total levels constant (Wera et al., 1995; Baharians and Schonthal, 1998) . To determine, which celltypes in the Harderian gland express the L309A transgene, paraffin sections obtained from 10-day-old transgenic and control glands were stained with an HA-specific antibody. This revealed expression of the transgene in cells of the L309A gland other than innervating nerves (Fig. 1B). 2.2. Altered recruitment of PP2A regulatory subunits into the PP2A complex in L309A mice Based on in vitro findings that residue L309 regulates the recruitment of regulatory subunits into the PP2A complex, we assessed the heterotrimer composition in L309A mutant Harderian gland by Western blotting. This serves as an indirect measure for the recruitment of regulatory subunits into the PP2A complex, as they are more stable in the bound than in the monomeric unbound form (Li et al., 2002; Silverstein et al., 2002) . Our study revealed an altered recruitment of regulatory subunits into the complex in L309A mice (Fig. 1C and D) . Relative levels of the scaffolding and the catalytic subunits were unaffected, based on normalization with glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hence, levels of regulatory subunits were normalized to the scaffolding subunit of PP2A, PPP2R1 (Fig. 1D ). In the Harderian gland, PPP2R2A (PR55a) was reduced to 46% and PPP2R5E (PR613) to 38%, whereas, PPP2R5C (PR61g) and PPP2R3A (PR59) were increased 2.5-and 3-fold, respectively, compared to WT (Fig. 1D ). For comparison, PPP2R2 (PR55) subunit levels were not altered in tissues such as the zygomatic muscle adjacent to the Harderian gland ( Fig. 1A and data not shown). Additional regulatory subunits have not been examined since specific antibodies are not available.
In summary, our data demonstrate that leucine 309 of the catalytic subunit controls PP2A regulatory subunit composition in vivo.
Enophthalmos (slit-eye phenotype) in L309A mice caused by hypoplasia of the Harderian gland
The L309A mice invariably demonstrated a slit-eye phenotype reminiscent of enophthalmos in man, which became evident at 2 weeks of age (Fig. 2 ). This phenotype might be caused by small eyes (microphthalmia) due to impaired development or atrophy, by changes of the retroocular structures including lacrimal glands, fatty tissue and muscles, or by defects of the bony orbia itself.
Sagittal sections of 2 and 11-month-old L309A mice revealed a normal structure, size and shape of the eye (data not shown) implying that altered retroocular structures caused the enophthalmos. Indeed, haematoxylin/eosin stainings of decalcified and paraffin embedded mouse heads showed marked changes in the transgenic Harderian gland whereas the bony orbits seemed to be unaffected (Fig. 3) . While in WT mice normal gland development starts perinatally, it was delayed in homogenates using an HA-specific antibody shows that the transgene is strongly expressed in the brain (data not shown) and the Harderian gland of L309A mice (TG). The zygomatic (cheek) muscle was included because of its proximity to the gland and brain. Expression is not detectable in skeletal muscle, lung, liver, heart, and spleen. Similarly, no expression is found in brain and gland of WT controls. An antibody directed against the catalytic subunit (Ca) of PP2A (endogenous and mutant) reveals that total levels are not increased upon expression of L309A. (B) Staining of sections obtained from 10-day-old transgenic and control gland with an HA-specific antibody reveals expression of the transgene in cells of the L309A gland, other than innervating nerves. (C,D) Immuno-blotting and subsequent quantification of density values. Relative levels of the scaffolding subunit PPP2R1 and the catalytic subunit PPP2CA were unaffected in L309A mice, based on comparison with GAPDH, and, therefore, levels of regulatory subunits were normalized to the scaffolding subunit. Mean values and standard errors are shown. In total extracts of the Harderian gland, PPP2R2A (PR55a) is reduced to 46% (five glands pooled) and PPP2R5E (PR613) to 38% (2!5 glands), and PPP2R5C (PR61g) and PPP2R3A (PR59) levels are increased 2.5-and 3-fold, respectively, when compared with WT controls for which levels were set to 100% (2!5 glands). The relative abundance of regulatory subunits is a measure of the degree of recruitment into the PP2A complex, as monomers are stabilized when bound to the core dimer.
L309A mice, as shown for postnatal day 3 (Fig. 3A,B) . WT mice start to develop an intact gland around birth, with secretory tubules and alveoli that grow considerably as the mice become older. The promoter used for L309A transgene expression is turned on at around embryonic day 16, shortly before the gland becomes visible in WT mice, and reaches maximal levels at postnatal day 28 (Kollias et al., 1987; Luthi et al., 1997) . At postnatal day 10, the L309A Harderian gland was tiny compared to WT (Fig. 3C,D) . While until postnatal day 12, the Harderian glands had grown rapidly in WT mice, causing the eyes to bulge, the transgene-induced hypoplasia of the Harderian gland in the L309A mice became at this age visible upon external inspection as it caused the eyes to sink deeply into the orbits (Fig. 2) . As a consequence of the impaired development of the Harderian gland in L309A mice, at postnatal day 18, most portions of the posterior aspect of the eyeball were devoid of glandular tissue (Fig. 3E,F ). Yet, cell types and the general glandular organization of the tissue were not affected. When 11-15-month-old L309A mice were examined, the Harderian gland was almost completely missing, with the average weight of the lacrimal system being reduced from 180 mg to less than a fourth (data not shown). To discriminate between degeneration of the L309A gland as compared to impaired development, TUNEL assays were performed. These were done at 1 and 10 days of age and revealed equal numbers of apoptotic cells in L309A and WT mice, suggesting that the L309A Harderian and lacrimal gland phenotype is caused by impaired development (data not shown).
To determine whether defective innervation may have contributed to small Harderian glands in L309A mice, sections from 18-day-old glands were stained with the neuron-specific antibodies NSE and PGP9.5. These revealed comparable numbers of nerve fibers with similar diameters in both WT and L309A glands (Fig. 4) . To test whether enophthalmos in L309A mice altered eye function, we performed Ganzfeld electroretinography (ERG) of 10-month-old L309A mice (nZ 4) and WT littermate controls (nZ4). This revealed normal retinal function in L309A mice lacking a proper Harderian gland (Fig. 5A) . Moreover, scanning laser ophthalmoscopy after contrast dye injection showed normal blood flow although a pulsation of larger veins occurred in L309A mice ( Fig. 5B and Supplementary film). Together, our data demonstrate that expression of PPP2CA L309A in the Harderian gland causes a delayed postnatal development and hypoplasia resulting in enophthalmos.
Defective cell adhesion in the L309A Harderian gland
We have previously shown defective cell adhesion in embryos lacking the catalytic subunit PPP2CA of PP2A (PP2A knockout mice), with reduced levels of b-catenin and E-cadherin. Both proteins were translocated to the cytoplasm, suggesting a role for PP2A in stabilizing the b-catenin/Ecadherin complex at the plasma membrane of early embryos (Gotz et al., 2000) . Although cadherins are integral membrane proteins, there are several reports of a cytoplasmic localization (Gotz et al., 2000; Gao et al., 2005) . When we addressed cell adhesion in the L309A mice, both cadherins and b-catenin showed prominent membrane localization in WT Harderian glands, but were significantly reduced and more broadly distributed throughout the cytoplasm in the L309A gland, similar to the findings in PP2A knockout mice (Fig. 6A-G) . We next performed a Western blot analysis of membrane and cytosolic fractions from Harderian gland. To confirm the purity of the fractions, antibodies specific for GAPDH and the carboxy-terminal fragment of the amyloid precursor protein, APP, were used ( Fig. 6G ; and data not shown).
In the WT Harderian gland, both cadherin and b-catenin were found in the cytosolic fraction with levels that were approximately three times lower than in the membrane fraction. In L309A glands, this ratio was preserved for cadherin, however, in both fractions levels were four times lower than in WT. In contrast, levels of b-catenin were reduced threefold in the cytosol of the L309A gland, but ninefold in the membrane fraction. These differences were determined by calculating density values of several Western blots. Together this indicates a major reduction of membrane-associated b-catenin in the L309A gland, resulting in similar levels of b-catenin both in the cytosolic and the membrane fraction (Fig. 6G) . In contrast to GAPDH, b-actin, which is associated with the cadherin-b-catenin complex through a-catenin, was hardly detectable in the cytosolic fraction of the L309A gland (Fig. 6G) . Also, L309A was found almost exclusively in the cytosolic fraction of the L309A gland (Fig. 6G) .
For cadherin, adhesion has previously been shown to depend both on casein kinase 2 (CK2) and glycogen synthase kinase-3b (GSK3-b) mediated phosphorylation . Since there are activity-dependent antibodies available for GSK-3b, but not CK2, we concentrated our analysis on GSK-3b, which is negatively regulated by phosphorylation at Ser-9 (Lau et al., 1999) . By immuno-blotting, an increased phosphorylation at Ser-9 of GSK-3b was found in the L309A gland, but not in zygomatic (cheek) muscle (Fig. 6H) . As total levels of GSK-3b were reduced in the L309A gland compared to WT, but not in zygomatic muscle, this indicates that relative levels of Ser-9 phosphorylated GSK-3b in the L309A gland are even higher.
Together, our data suggest a role for distinct PP2A heterotrimers in stabilizing b-catenin and cadherin in the plasma membrane of the Harderian gland. Altering PP2A subunit composition, therefore, has functional consequences for the cyto-architecture of the gland.
Discussion
In the present study, we showed that the serine/threoninedirected protein phosphatase PP2A is required for development and integrity of the Harderian gland. Specifically, we demonstrated that the carboxy-terminal amino acid L309 of the catalytic subunit of PP2A plays a crucial role in regulating PP2A subunit composition and thereby controls cell adhesion in the Harderian gland.
Our findings were obtained in transgenic mice expressing the mutant form of the catalytic subunit of PP2A, PPP2CA L309A, in Harderian gland. We invariably observed an enophthalmos (slit-eye phenotype) in L309A mice that was not caused by motor deficits (data not shown) or eye irritations. Instead, a depression of the eyeball was found within the orbit caused by a delayed and aberrant development of the transgenic Harderian gland. Eventually, when L309A mice reached an age of 11-15 months, the Harderian gland was hardly detectable. Yet, the little remaining glandular structure was intact, with no evidence of alterations in glandular cell types. Degeneration of the Harderian gland in our L309A mice strikingly resembles that caused by prenatal exposure to 2,4-dichlorophenyl-p-nitrophenyl ether (nitrofen; NIT) (Gray et al., 1982) , where a role of PP2A has been suggested (Lazzereschi et al., 1997; Arufe et al., 1999) . The glandular phenotype observed in our mice is unlikely caused by defective or reduced parasympathetic innervation, as the neuron-specific antibodies NSE and PGP9.5 revealed comparable numbers of nerve fibers with similar diameters in both WT and L309A glands.
To investigate the nature of PP2A dysfunction responsible for the Harderian gland phenotype in our mice, we determined the PP2A subunit composition in the gland in more detail. Based on in vitro findings that L309A can alter the binding capacity of individual regulatory subunits to the PP2A dimer, we assessed the PP2A heterotrimer composition in L309A mutant gland by Western blotting. This approach was based on the assumption that regulatory subunits, which are not recruited by the core dimer are degraded more rapidly and are, therefore, less abundant in vivo, a model proposed earlier in Drosophila Schneider cells (Li et al., 2002; Silverstein et al., 2002) . The notion that the various regulatory subunits may be produced in abundance and compete for binding to the core dimer is supported by our finding that PPP2R2A (PR55a) and PPP2R5E (PR613) were decreased, whereas in the same tissue PPP2R5C (PR61g) and PPP2R3A (PR59) were increased. Glandular cells such as these of the Harderian gland under physiologic conditions form a tight united cell structure, with the PP2A substrates cadherin and b-catenin playing crucial roles in stabilizing cell-cell contacts. Both proteins are essential for tissue maintenance as demonstrated by the embryonic lethality encountered in b-catenin or cadherin knockout mice (Larue et al., 1994; Haegel et al., 1995; Lee et al., 2004) . When we addressed cell adhesion in the L309A mice, both PP2A substrates showed prominent membrane localization in WT Harderian glands, but were significantly reduced and more broadly distributed throughout the cytoplasm in the L309A gland. Interestingly, when PP2A was inhibited with okadaic acid in human epidermal cell cultures this not only caused demethylation of leucine 309, but also induced hyperphosphorylation of b-catenin and loss of cell-cell contact (Favre et al., 1997; Serres et al., 1997; Serres et al., 2000) . We have previously shown defective cell adhesion in PP2A knockout embryos (Gotz et al., 2000) . There, cellular levels of b-catenin and E-cadherin were also reduced, and both proteins were translocated to the cytoplasm, suggesting a role for PP2A in stabilizing the E-cadherin/b-catenin complex at the plasma membrane in blastocysts (Gotz et al., 2000) and the Harderian gland. With Harderian gland development being very similar to lung development, transgenic expression of the PPP2R5C (PR56g) subunit of PP2A has been shown to cause disrupted distal lung development again associated with decreased b-catenin levels (Everett et al., 2002) . Similarly, transgenic overexpression of b-catenin dramatically changed lung epithelial development (Okubo and Hogan, 2004) .
In the present L309A mouse model, reduced membrane levels of cadherins and b-catenin in the gland may, in part, also be due to altered phosphorylation. However, this is difficult to L309A glands show similar levels of b-catenin in both membrane (me) and cytosolic (cy) fractions, whereas in WT, b-catenin is three times more abundant in the membrane fraction as determined by calculating density values. Levels of cadherins are reduced fourfold in both fractions in the L309A compared to the WT gland. b-Actin is hardly detectable in the cytosolic fraction of the L309A gland, and PPP2CA (Ca) L309A is found almost exclusively in the cytosolic fraction. Total levels of GSK-3a and GSK-3b are reduced in the L309A gland, whereas phosphorylation at Ser-9 is increased. Purity of the fractions was confirmed with GAPDH-and amyloid precursor protein-specific antibodies.
assess as no phosphosite-specific antibodies are available for those serine and threonine residues of cadherin that regulate cell adhesion . For cadherin, adhesion was shown to depend on casein kinase 2 (CK2)-and GSK3-bmediated phosphorylation . Treatment of keratinocytes with okadaic acid caused a decrease in cadherin phosphorylation and relocation from the membrane to the cytoplasm and thereby prevented cells from forming aggregates (Serres et al., 2000) . In L309A Harderian gland, the altered localization of cadherin could be due to a reduced phosphorylation by GSK-3b, which is itself negatively regulated by phosphorylation at Ser-9 (Lau et al., 1999) . Indeed, we found an increased phosphorylation of GSK-3b at this epitope in the L309A gland, which may reduce its activity towards cadherin and thereby weaken cell adhesion . Moreover, we found that b-actin was reduced to hardly detectable levels in the cytosolic fraction of the Harderian gland. b-actin may be destabilized due to an impaired interaction with the cadherin-b-catenin complex through a-catenin. As PP2A has a range of substrates with a putative role in cell adhesion, the relative impact of their phosphorylation status on cell adhesion still needs to be established.
In conclusion, our data show that the carboxy-terminal leucine L309 of the catalytic subunit of PP2A determines PP2A heterotrimer composition in vivo. Accordingly, recruitment of specific regulatory subunits into the PP2A complex is associated with decreased recruitment of other subunits. Moreover, this suggests that PP2A in general and its heterotrimer composition in particular play a crucial role in cell adhesion and as a consequence in proper development of the Harderian gland. Taking into account that PP2A may execute similar functions in other glandular tissues, the L309A mice may, therefore, be a suitable model to further investigate gland function.
Experimental procedures
Generation of transgenic mice
A 978 bp cDNA fragment encoding human PPP2CA was fused to a haemagglutinin (HA) epitope located immediately downstream of the start codon. The L309A amino acid substitution was introduced into the cDNA using the QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). The mutated fragment was subcloned into the neuron-specific murine Thy1.2 expression vector (Luthi et al., 1997) . For pronuclear injection, vector sequences were removed and the DNA was purified with PrepAGene (BioRad, Hercules, CA) and Millipore Ultrafree-MC 0.22 mm filter units. Transgenic mice were produced by microinjection of B6D2F1!B6D2F1 embryos (Gotz et al., 1995) . Founders were identified by PCR analysis of tail lysates using oligonucleotides Thy1.2 (5 0 -AAGTCACCCAGCAGG-GAGGTGCTC-3 0 ) and PP2ACa (5 0 -TCTCGCAGAGGCTCTT GACCTGGG AC-3 0 ), and intercrossed with C57BL/6 mice to establish lines.
Animal ethics
All experiments were performed according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research (http://www.arvo.org/ AboutARVO/animalst.asp).
Antibodies
Antibodies used for Western blot (WB) analysis or immunohistochemistry (IH) were: HA (Roche, Basel, Switzerland, IH 1:200, WB 1:1000); antiserum 45 (Dr B. Hemmings, Basel, Switzerland, anti-PPP2CA; directed against the first 20 amino acids, WB 1:100) (Gotz et al., 1998) ; PPP2C (Oncogene Research Products, Cambridge, MA, WB 1:100); PPP2R1, 6G3 (Covance, Berkeley, CA, WB 1:1000); PPP2R2A (Calbiochem, San Diego, CA, WB 1:500); PPP2R5C and PPP2R5E (Dr B. Hemmings, WB 1:300); b-actin (Abcam, Cambridge, MA, WB 1:5000); b-catenin (Biodesign International, Saco, ME, IH 1:100, WB 1:500); glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Biodesign International, WB 1:1000); NSE (DakoCytomation, Glostrup, Denmark, IH 1:200); PGP9.5 (Abcam, WB 1:2000); Pan cadherin (Lab Vision, Fremont, CA, IH 1:100, WB 1:500); GSK-3b (Santa Cruz Biotechnology, Santa Cruz, CA, WB 1:500); p-GSK-3b (Ser 9) (Santa Cruz Biotechnology, WB 1:500); amyloid precursor protein C-terminal (SigmaAldrich, St Louis, MO, WB 1:4000). The rabbit anti-PR59 antiserum D1-113 (WB: 1:5000) was raised against a fusion protein containing a 6!HIS-tag fused to amino acids 114-521 of murine PR59. For immunofluorescence, secondary antibodies were obtained from Molecular Probes (Alexa-Fluor series, Eugene, OR), and for immunoblotting, HRP-conjugated secondary antibodies (Vector Laboratories, Burlingame, CA) were used. For peroxidase/ DAB staining, secondary antibodies were obtained from Vector Laboratories (Vectastain ABC kits PK-6101 and PK-6102).
Immunohistochemistry and TUNEL assays
For immunohistochemistry, mice were perfused transcardially with 4% paraformaldehyde in phosphate-buffered saline (PBS). Four micrometre methanol-permeabilized, paraffin-embedded parasagittal brain sections were stained using standard published procedures (Gotz et al., 1998) . Some sections were pretreated with 5 mg/ml proteinase K or 0.1% Triton X-100 in Trisbuffered saline (TBST) for 2.5 min at 37 8C for signal enhancement. 40 mm vibratome sections were permeabilized with 0.1% NP-40 (Calbiochem). Sections were dehydrated in an ascending series of ethanol and flat-embedded between glass slides and coverslips in Moviol 4-88 (Roche) containing 2.5% (w/v) DABCO (Sigma-Aldrich). TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling) staining: To detect cells undergoing apoptosis, the POD in situ cell death detection kit (Boehringer Mannheim, no. 1684817) was used as described (Gavrieli et al., 1992; Gotz et al., 2001; Wurdak et al., 2005) .
Decalcification and haematoxylin/eosin (HE) staining of mouse heads
After perfusion with 4% paraformaldehyde, mouse heads were washed in PBS followed by H 2 O. Then they were decalcified at room temperature for 3-4 days in a solution of 0.15 M EDTA and 70 mM HCl, pH 6.5. After washing with H 2 O, the heads were dehydrated and embedded in paraffin. Four micrometre sections were incubated in haematoxylin for 15 min, hydrated, differentiated in 0.25% HCl in 50% ethanol, rehydrated, and rinsed in 96% ethanol. Sections were incubated in eosin for 5 s, rinsed in 70% ethanol, dehydrated, and mounted in Eukitt (Kindler, Freiburg, Germany).
Immunoblotting
For immunoblotting, extracts were prepared with a teflon homogenizer in a buffer containing 70 mM Tris, 150 mM NaCl, pH 8, and 1% (v/v) Triton X-100 in the presence of protease inhibitors (Completee with EDTA, Roche). Homogenates from pooled glands were allowed to stand on ice for 30 min followed by centrifugation for 30 min at 20,000!g. For cell fractionation, a buffer containing 20 mM Tris-HCl, pH 7.4, 250 mM sucrose, 1 mM DTT and protease inhibitors was used. Lysates were centrifuged for 45 min at 100,000!g to separate the cytosolic fraction. The pellet was resuspended with 0.5% Triton X-100 and 5 mM EGTA in lysis buffer and centrifuged for 30 min at 100,000!g. The supernatant was taken as membrane fraction.
Protein content was normalized using the D C protein assay (Bio-Rad). Extracts were separated by SDS-PAGE, followed by electrophoretic transfer onto a 0.45 mm nitrocellulose membrane (Bio-Rad). Ponceau stainings were included to confirm equal loading. Membranes were blocked with 6% dry milk in TBST and reacted with primary and HRP-conjugated secondary antibodies. Density values were calculated with the ImageJ software (Wayne Rasband, NIH, USA).
Ganzfeld electroretinography (ERG) and scanning laser ophthalmoscopy (SLO)
Electroretinograms were obtained according to procedures previously described (Seeliger et al., 2001) . In summary, mice were dark-adapted overnight and their pupils dilated prior to the experiments. The animals were anesthetized by subcutaneous injection of ketamine (66.7 mg/kg) and xylazine (11.7 mg/kg). ERGs were binocularly recorded from the corneal surface by means of gold wire ring electrodes, and silver needle electrodes served as reference (forehead) and ground (tail). The ERG equipment consisted of a Ganzfeld bowl, a DC amplifier, and a PC-based control and recording unit (Toennies Multiliner Vision, Jaeger/Toennies, Höchberg, Germany). Bandpass filter cut-off frequencies were 0.1 and 3000 Hz. Single flash recordings were obtained both under dark-adapted (scotopic) and light-adapted (photopic) conditions. The light adapted part was performed with a background illumination of 30 cd m K2 that started 10 min before the first recording. Stimuli were presented with increasing intensities from 10 K4 to 25 cd s m K2 , divided into ten steps of 0.5 and 1 log cd s m
K2
. Ten responses were averaged with an inter-stimulus interval (ISI) of 5 or 17 s (for 1, 3, 10, 25 cd s m K2 ). Imaging was performed with a Heidelberg Retina Angiograph (HRA1, Heidelberg Engineering GmbH, Dossenheim, Germany), a confocal scanninglaser ophthalmoscope providing two laser wavelengths for fundus visualization (Argon green, 514 nm, and infrared, 835 nm), and two laser wavelengths for angiography (Argon blue, 488 nm (barrier 500 nm) for fluorescence angiography, and infrared, 795 nm (barrier 810 nm) for indocyanine green (ICG) angiography). Fluoresceine angiography was performed following a s.c. injection of 1.5 mg fluorescein-Na (University pharmacy, University of Tuebingen), and ICG angiography following a s.c. injection of 1 mg ICG (ICG-Pulsion, Pulsion Medical Systems AG, Munich, Germany).
